"While many individuals taking GLP-1 and GIP inhibitors report a reduction in food noise, these medications are not FDA-approved to treat food preoccupation and its related impulsivity," he said
Additionally, by binding to GLP-1 receptors in enteric neurons and endocrine cells, these agents slow gastric motility, reduce acid secretion, and modulate appetite through satiety signaling to the hypothalamus [3]
The relative effects of fat versus muscle mass on cystatin C and estimates of renal function in healthy young men
Focusing on drugs with established safety profiles should accelerate translation if we find promising candidates
Interesting information i would be curious as well to find out if any muscle mass was lost at all if someone on a GLP-1 started working out when they first were starting the medication
Janatuinen E, Pikkarainen P, Laakso M, et al